These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7904734)

  • 1. Creutzfeldt-Jakob disease after pituitary-derived human growth hormone therapy: two cases with valine 129 homozygous genotype.
    Masson C; Delalande I; Deslys JP; Hénin D; Fallet-Bianco C; Dormont D; Leys D
    Neurology; 1994 Jan; 44(1):179-80. PubMed ID: 7904734
    [No Abstract]   [Full Text] [Related]  

  • 2. Valine homozygous 129 PrP genotype in a French growth-hormone-related Creutzfeldt-Jakob disease patient.
    Labauge P; Pagès M; Blard JM; Chatelain J; Laplanche JL
    Neurology; 1993 Feb; 43(2):447. PubMed ID: 8437720
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
    Collinge J; Palmer MS; Dryden AJ
    Lancet; 1991 Jun; 337(8755):1441-2. PubMed ID: 1675319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with extractive growth hormone and Creutzfeld-Jakob encephalopathy: a new iatrogenic tragedy].
    Battin J
    Pediatrie; 1993; 48(2):91-5. PubMed ID: 8393184
    [No Abstract]   [Full Text] [Related]  

  • 5. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
    Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
    Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.
    Marzewski DJ; Towfighi J; Harrington MG; Merril CR; Brown P
    Neurology; 1988 Jul; 38(7):1131-3. PubMed ID: 3290703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CJD discrepancy.
    Doh-ura K; Kitamoto T; Sakaki Y; Tateishi J
    Nature; 1991 Oct; 353(6347):801-2. PubMed ID: 1682813
    [No Abstract]   [Full Text] [Related]  

  • 8. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease.
    Alperovitch A; Zerr I; Pocchiari M; Mitrova E; de Pedro Cuesta J; Hegyi I; Collins S; Kretzschmar H; van Duijn C; Will RG
    Lancet; 1999 May; 353(9165):1673-4. PubMed ID: 10335789
    [No Abstract]   [Full Text] [Related]  

  • 9. The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy.
    Brown P
    Neurology; 1988 Jul; 38(7):1135-7. PubMed ID: 3290705
    [No Abstract]   [Full Text] [Related]  

  • 10. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
    Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
    Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal proteins in the cerebrospinal fluid of a patient with Creutzfeldt-Jakob disease following administration of human pituitary growth hormone.
    Macário ME; Moura-Neto V; Vaisman M; Araujo HM; Buescu A; Cordeiro JG; Chagas C
    Braz J Med Biol Res; 1992; 25(11):1127-30. PubMed ID: 1342593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease: search for a genetic susceptibility by analysis of the PRNP coding region.
    Jaegly A; Boussin F; Deslys JP; Dormont D
    Genomics; 1995 May; 27(2):382-3. PubMed ID: 7558015
    [No Abstract]   [Full Text] [Related]  

  • 13. [Creutzfeldt-Jakob disease secondary to treatment with growth hormone].
    Beauvais P; Billette de Villemeur T
    Presse Med; 1993 Jun; 22(23):1077-8. PubMed ID: 8415458
    [No Abstract]   [Full Text] [Related]  

  • 14. Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient.
    New MI; Brown P; Temeck JW; Owens C; Hedley-Whyte ET; Richardson EP
    Neurology; 1988 Jul; 38(7):1133-4. PubMed ID: 3290704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine.
    Brown P; Cervenáková L; Goldfarb LG; McCombie WR; Rubenstein R; Will RG; Pocchiari M; Martinez-Lage JF; Scalici C; Masullo C
    Neurology; 1994 Feb; 44(2):291-3. PubMed ID: 8309577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Macario ME; Vaisman M; Buescu A; Moura Neto V; Araujo HM; Chagas C
    BMJ; 1991 May; 302(6785):1149. PubMed ID: 2043794
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prions, Jakob-Creutzfeldt disease and human growth hormone].
    González PM
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):207-9. PubMed ID: 3296112
    [No Abstract]   [Full Text] [Related]  

  • 18. Eternal vigilance--mortality in children with growth hormone deficiency.
    Hintz RL
    J Clin Endocrinol Metab; 1996 May; 81(5):1691-2. PubMed ID: 8626816
    [No Abstract]   [Full Text] [Related]  

  • 19. Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene.
    Komatsu J; Sakai K; Hamaguchi T; Sugiyama Y; Iwasa K; Yamada M
    Prion; 2014; 8(5):336-8. PubMed ID: 25495585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development.
    Mitrová E; Belay G
    Acta Virol; 2002; 46(1):31-9. PubMed ID: 12197632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.